List of Tables
    Table 1. Key Players of Vaccines Administered Orally in Global Market
    Table 2. Top Vaccines Administered Orally Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global Vaccines Administered Orally Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global Vaccines Administered Orally Revenue Share by Companies, 2017-2022
    Table 5. Global Vaccines Administered Orally Sales by Companies, (K Units), 2017-2022
    Table 6. Global Vaccines Administered Orally Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers Vaccines Administered Orally Price (2017-2022) & (US$/Unit)
    Table 8. Global Manufacturers Vaccines Administered Orally Product Type
    Table 9. List of Global Tier 1 Vaccines Administered Orally Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Vaccines Administered Orally Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Vaccines Administered Orally Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Global Vaccines Administered Orally Revenue (US$, Mn), 2017-2022
    Table 13. By Type - Global Vaccines Administered Orally Revenue (US$, Mn), 2023-2028
    Table 14. By Type - Global Vaccines Administered Orally Sales (K Units), 2017-2022
    Table 15. By Type - Global Vaccines Administered Orally Sales (K Units), 2023-2028
    Table 16. By Application – Global Vaccines Administered Orally Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Application - Global Vaccines Administered Orally Revenue (US$, Mn), 2017-2022
    Table 18. By Application - Global Vaccines Administered Orally Revenue (US$, Mn), 2023-2028
    Table 19. By Application - Global Vaccines Administered Orally Sales (K Units), 2017-2022
    Table 20. By Application - Global Vaccines Administered Orally Sales (K Units), 2023-2028
    Table 21. By Region – Global Vaccines Administered Orally Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global Vaccines Administered Orally Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global Vaccines Administered Orally Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global Vaccines Administered Orally Sales (K Units), 2017-2022
    Table 25. By Region - Global Vaccines Administered Orally Sales (K Units), 2023-2028
    Table 26. By Country - North America Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America Vaccines Administered Orally Sales, (K Units), 2017-2022
    Table 29. By Country - North America Vaccines Administered Orally Sales, (K Units), 2023-2028
    Table 30. By Country - Europe Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe Vaccines Administered Orally Sales, (K Units), 2017-2022
    Table 33. By Country - Europe Vaccines Administered Orally Sales, (K Units), 2023-2028
    Table 34. By Region - Asia Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia Vaccines Administered Orally Sales, (K Units), 2017-2022
    Table 37. By Region - Asia Vaccines Administered Orally Sales, (K Units), 2023-2028
    Table 38. By Country - South America Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America Vaccines Administered Orally Sales, (K Units), 2017-2022
    Table 41. By Country - South America Vaccines Administered Orally Sales, (K Units), 2023-2028
    Table 42. By Country - Middle East & Africa Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa Vaccines Administered Orally Sales, (K Units), 2017-2022
    Table 45. By Country - Middle East & Africa Vaccines Administered Orally Sales, (K Units), 2023-2028
    Table 46. Merck Corporate Summary
    Table 47. Merck Vaccines Administered Orally Product Offerings
    Table 48. Merck Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 49. GSK Corporate Summary
    Table 50. GSK Vaccines Administered Orally Product Offerings
    Table 51. GSK Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 52. Sanofi Corporate Summary
    Table 53. Sanofi Vaccines Administered Orally Product Offerings
    Table 54. Sanofi Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 55. Lanzhou Institute Corporate Summary
    Table 56. Lanzhou Institute Vaccines Administered Orally Product Offerings
    Table 57. Lanzhou Institute Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 58. Serum Institute Corporate Summary
    Table 59. Serum Institute Vaccines Administered Orally Product Offerings
    Table 60. Serum Institute Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 61. Valneva Corporate Summary
    Table 62. Valneva Vaccines Administered Orally Product Offerings
    Table 63. Valneva Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 64. Shanghai United Cell Corporate Summary
    Table 65. Shanghai United Cell Vaccines Administered Orally Product Offerings
    Table 66. Shanghai United Cell Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 67. Bibcol Corporate Summary
    Table 68. Bibcol Vaccines Administered Orally Product Offerings
    Table 69. Bibcol Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 70. PaxVax Corporate Summary
    Table 71. PaxVax Vaccines Administered Orally Product Offerings
    Table 72. PaxVax Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 73. Vabiotech Corporate Summary
    Table 74. Vabiotech Vaccines Administered Orally Product Offerings
    Table 75. Vabiotech Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 76. Tiantan Biological Corporate Summary
    Table 77. Tiantan Biological Vaccines Administered Orally Product Offerings
    Table 78. Tiantan Biological Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 79. EuBiologics Corporate Summary
    Table 80. EuBiologics Vaccines Administered Orally Product Offerings
    Table 81. EuBiologics Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 82. Panacea Biotec Ltd Corporate Summary
    Table 83. Panacea Biotec Ltd Vaccines Administered Orally Product Offerings
    Table 84. Panacea Biotec Ltd Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 85. Bio-Med Corporate Summary
    Table 86. Bio-Med Vaccines Administered Orally Product Offerings
    Table 87. Bio-Med Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 88. Halfkin Bio-Pharmaceuticals Corporate Summary
    Table 89. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Offerings
    Table 90. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 91. Vaccines Administered Orally Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
    Table 92. Global Vaccines Administered Orally Capacity Market Share of Key Manufacturers, 2020-2022
    Table 93. Global Vaccines Administered Orally Production by Region, 2017-2022 (K Units)
    Table 94. Global Vaccines Administered Orally Production by Region, 2023-2028 (K Units)
    Table 95. Vaccines Administered Orally Market Opportunities & Trends in Global Market
    Table 96. Vaccines Administered Orally Market Drivers in Global Market
    Table 97. Vaccines Administered Orally Market Restraints in Global Market
    Table 98. Vaccines Administered Orally Raw Materials
    Table 99. Vaccines Administered Orally Raw Materials Suppliers in Global Market
    Table 100. Typical Vaccines Administered Orally Downstream
    Table 101. Vaccines Administered Orally Downstream Clients in Global Market
    Table 102. Vaccines Administered Orally Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Vaccines Administered Orally Segment by Type
    Figure 2. Vaccines Administered Orally Segment by Application
    Figure 3. Global Vaccines Administered Orally Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Vaccines Administered Orally Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Vaccines Administered Orally Revenue, 2017-2028 (US$, Mn)
    Figure 7. Vaccines Administered Orally Sales in Global Market: 2017-2028 (K Units)
    Figure 8. The Top 3 and 5 Players Market Share by Vaccines Administered Orally Revenue in 2021
    Figure 9. By Type - Global Vaccines Administered Orally Sales Market Share, 2017-2028
    Figure 10. By Type - Global Vaccines Administered Orally Revenue Market Share, 2017-2028
    Figure 11. By Type - Global Vaccines Administered Orally Price (US$/Unit), 2017-2028
    Figure 12. By Application - Global Vaccines Administered Orally Sales Market Share, 2017-2028
    Figure 13. By Application - Global Vaccines Administered Orally Revenue Market Share, 2017-2028
    Figure 14. By Application - Global Vaccines Administered Orally Price (US$/Unit), 2017-2028
    Figure 15. By Region - Global Vaccines Administered Orally Sales Market Share, 2017-2028
    Figure 16. By Region - Global Vaccines Administered Orally Revenue Market Share, 2017-2028
    Figure 17. By Country - North America Vaccines Administered Orally Revenue Market Share, 2017-2028
    Figure 18. By Country - North America Vaccines Administered Orally Sales Market Share, 2017-2028
    Figure 19. US Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe Vaccines Administered Orally Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe Vaccines Administered Orally Sales Market Share, 2017-2028
    Figure 24. Germany Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 25. France Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia Vaccines Administered Orally Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia Vaccines Administered Orally Sales Market Share, 2017-2028
    Figure 33. China Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 37. India Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America Vaccines Administered Orally Revenue Market Share, 2017-2028
    Figure 39. By Country - South America Vaccines Administered Orally Sales Market Share, 2017-2028
    Figure 40. Brazil Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa Vaccines Administered Orally Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa Vaccines Administered Orally Sales Market Share, 2017-2028
    Figure 44. Turkey Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 48. Global Vaccines Administered Orally Production Capacity (K Units), 2017-2028
    Figure 49. The Percentage of Production Vaccines Administered Orally by Region, 2021 VS 2028
    Figure 50. Vaccines Administered Orally Industry Value Chain
    Figure 51. Marketing Channels